Bone metastasis is one of the most common complications of malignant tumors. Autopsy shows that 85% of malignant tumors have bone metastasis, and the incidence of bone metastasis in patients with prostate cancer, breast cancer and lung cancer can reach more than 80%. The survival time of patients with advanced cancer continues to prolong, and the risk of bone metastasis and bone-related events (Skeletal-related events,SREs) increases significantly. Bone metastasis of malignant tumor can lead to a series of bone-related events, such as intractable bone pain, dysfunction, pathological fracture, hypercalcemia and so on. In particular, extensive bone metastasis and intractable bone pain seriously affect the prognosis and quality of life of patients. Early detection of bone metastases is very important for accurate clinical staging, selection of follow-up treatment strategies, reducing the risk of complications and improving the quality of life. With the continuous improvement of diagnostic technology and treatment level of malignant tumors, the basic and clinical research of bone metastasis has made great progress, especially in the early diagnosis and effective treatment of bone metastases. People pay more and more attention to the comprehensive treatment of malignant tumor after metastasis to bone. At present, the common treatment methods of bone metastases are surgery, external radiation therapy, radionuclide therapy, hormone therapy, chemical drug therapy and traditional Chinese medicine therapy and so on. Among them, targeted radionuclide radiotherapy is a rapidly developing method in recent years, which has the advantages of good curative effect, simple method and less side effects. therefore, this method has become a new and effective treatment for bone metastasis and pain caused by tumor. This consensus brings together experts from nuclear medicine, orthopaedics, oncology, anaesthesia and pain, imaging, radiotherapy, mental health and other multidisciplinary experts, focusing on radionuclide therapy and highlighting multidisciplinary MDT comprehensive evaluation and treatment.

In burn patients, especially patients with respiratory tract burns, the clinical diagnosis mostly depends on symptoms, signs and X-ray chest radiograph, and the condition is insidious. Because airway necrotic tissue, secretions cause obstruction and infection, peeling of airway mucosa or airway ulcer cause massive bleeding, it has become one of the main causes of death in burn patients. In recent years, with the wide application of fiberoptic bronchoscopy, fiberoptic bronchoscopy has also been gradually applied in the diagnosis and treatment of respiratory burn patients, and has played a certain role. This consensus will further standardize the clinical application of burn bronchoalveolar lavage in adults.

Primary health care is not only the core of the national health system but also the cornerstone of achieving the United Nations Sustainable Development Goals and universal health coverage. This guide, which is organized by the Chinese Academy of Medical Sciences, Peking University, and the China Primary Health Care Journal Office, brings together national experts to develop guidelines suitable for China's national conditions by synthesizing domestic and international research evidence, guidelines, and domestic primary health care management and practice experience. It provides technical standards for primary health care services and promotes the construction of a people-centered, integrated primary health care system.

Migraine is a highly disabling neurological disorder that affects over 1 billion people globally. Migraines are characterized by severe pain and may be accompanied by symptoms such as nausea, vomiting, photophobia and phonophobia, significantly impacting work and daily life. Current treatment methods include acute treatment and preventive treatment. The goal of acute treatment is to rapidly and sustainably alleviate pain and migraine-related symptoms, which is particularly important for improving the quality of life. However, excessive use of acute treatments or addictive acute treatment medications may lead to medication overuse headache, further contributing to chronic and refractory headaches. Additionally, there is currently a lack of standardized acute treatment guidelines for specific patient populations in China. In recent years, with the continuous development of new medications and the emergence of neurostimulation therapies, novel acute treatment approaches for migraines have emerged. Therefore, Chinese Medical Doctor Association and Chinese Research Hospital Association jointly initiated the development of these guidelines for acute migraine treatment, aiming to provide a basis for standardizing migraine treatment.